Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Accounts Payables (2021 - 2025)

Lucid Diagnostics (LUCD) has disclosed Accounts Payables for 5 consecutive years, with $2.3 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Accounts Payables rose 100.62% year-over-year to $2.3 million, compared with a TTM value of $2.3 million through Sep 2025, up 100.62%, and an annual FY2024 reading of $2.8 million, up 146.86% over the prior year.
  • Accounts Payables was $2.3 million for Q3 2025 at Lucid Diagnostics, up from $833000.0 in the prior quarter.
  • Across five years, Accounts Payables topped out at $4.5 million in Q1 2022 and bottomed at $307533.0 in Q3 2021.
  • Average Accounts Payables over 5 years is $1.6 million, with a median of $1.1 million recorded in 2024.
  • The sharpest move saw Accounts Payables soared 258.34% in 2022, then plummeted 65.8% in 2024.
  • Year by year, Accounts Payables stood at $1.1 million in 2021, then skyrocketed by 30.01% to $1.4 million in 2022, then fell by 20.8% to $1.1 million in 2023, then surged by 146.86% to $2.8 million in 2024, then decreased by 19.51% to $2.3 million in 2025.
  • Business Quant data shows Accounts Payables for LUCD at $2.3 million in Q3 2025, $833000.0 in Q2 2025, and $829000.0 in Q1 2025.